Join to View Full Profile
1 Hoag Dr# 6100Newport Beach, CA 92663
Phone+1 949-574-4694
Fax+1 877-742-1433
Dr. Huang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Patty Huang, MD is an Internal Medicine specialist based in Newport Beach, CA, with a subspeciality in Hospital Medicine/Hospitalist. Dr. Huang completed her residency in Internal Medicine at Los Angeles County-Harbor-UCLA Medical Center from 1997 - 2000, and she is a graduate from New York University School of Medicine, class of 1997. She has contributed to several publications in the field specifically in Leukemia, exploring topics such as the Loss of p53 pathway in CLL, killing of Gleevec-resistant CML cells, and targeting mTOR in lymphoma and leukemia cells.
Education & Training
Albany Med Health SystemResidency, Pulmonary Disease and Critical Care Medicine, 2021 - 2027
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1997 - 2000
New York University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2028
NY State Medical License 2002 - 2004
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 44 citationsLoss of p53 and altered miR15-a/16-1→MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cellsJinyun Liu, Jinyun Liu, Gang Chen, Li Feng, Wan Zhang
Leukemia. 2014-01-01 - 83 citationsEffective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism.Hui Zhang, Dunyaporn Trachootham, Weiqin Lu, Jennifer S. Carew, Francis J. Giles
Leukemia. 2008-04-03 - 83 citationsSynergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.Rui-Hua Xu, Helene Pelicano, Hui Zhang, Francis J. Giles, Michael J. Keating
Leukemia. 2005-12-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
